Homology Medicines (FIXX) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free FIXX Stock Alerts Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Homology Medicines Short Interest DataCurrent Short Volume338,700 sharesPrevious Short Volume322,300 sharesChange Vs. Previous Month+5.09%Dollar Volume Sold Short$311,604.00Short Interest Ratio / Days to Cover0.9Last Record DateFebruary 29, 2024Outstanding Shares58,130,000 sharesFloat Size41,980,000 sharesShort Percent of Float0.81%Today's Trading Volume401,400 sharesAverage Trading Volume390,307 sharesToday's Volume Vs. Average103% Short Selling Homology Medicines ? Sign up to receive the latest short interest report for Homology Medicines and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFIXX Short Interest Over TimeFIXX Days to Cover Over TimeFIXX Percentage of Float Shorted Over Time Ad Priority GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.Click here for your free guide Homology Medicines Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/2024338,700 shares $311,604.00 +5.1%0.8%0.9 $0.92 2/15/2024322,300 shares $232,056.00 +2.2%0.8%0.9 $0.72 1/31/2024315,400 shares $211,318.00 +8.4%0.8%0.8 $0.67 1/15/2024291,100 shares $173,582.93 -4.9%0.7%0.9 $0.60 12/31/2023306,100 shares $186,108.80 -19.5%0.7%0.9 $0.61 12/15/2023380,000 shares $208,240.00 -14.3%0.9%1.2 $0.55 Get the Latest News and Ratings for FIXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Homology Medicines and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023443,300 shares $235,392.30 +48.9%1.1%1.4 $0.53 11/15/2023297,800 shares $262,034.22 -6.7%0.7%1 $0.88 10/31/2023319,000 shares $331,760.00 +4.0%0.8%2.1 $1.04 10/15/2023306,700 shares $337,370.00 +23.3%0.7%0.9 $1.10 9/30/2023248,700 shares $290,979.00 -11.2%0.6%0.7 $1.17 9/15/2023280,100 shares $327,717.00 +0.1%0.7%0.8 $1.17 8/31/2023279,700 shares $335,640.00 -10.5%0.7%0.8 $1.20 8/15/2023312,600 shares $375,120.00 -1.5%0.8%0.9 $1.20 7/31/2023317,500 shares $441,325.00 +11.1%0.8%1 $1.39 7/15/2023285,800 shares $271,510.00 +9.2%0.7%2.2 $0.95 6/30/2023261,800 shares $231,693.00 -14.2%0.6%2.3 $0.89 6/15/2023305,100 shares $305,100.00 +10.0%0.7%2.7 $1.00 5/31/2023277,500 shares $271,034.25 +3.2%0.7%1.9 $0.98 5/15/2023268,800 shares $274,176.00 -23.4%0.6%1.7 $1.02 4/30/2023351,000 shares $333,450.00 -14.4%0.7%2.3 $0.95 4/15/2023409,800 shares $422,094.00 -3.4%0.8%2.8 $1.03 3/31/2023424,400 shares $437,132.00 +22.4%0.8%2.8 $1.03 3/15/2023346,800 shares $350,268.00 -0.7%0.7%2.1 $1.01 2/28/2023349,200 shares $530,784.00 -13.7%0.8%2.7 $1.52 2/15/2023404,500 shares $598,660.00 -16.1%1.0%2.9 $1.48 1/31/2023482,200 shares $757,054.00 -12.3%1.2%3.1 $1.57 1/15/2023550,100 shares $902,164.00 -10.6%1.4%3.4 $1.64 12/30/2022615,100 shares $775,026.00 -10.4%1.5%3.6 $1.26 12/15/2022686,300 shares $1.03 million -13.4%1.7%3.8 $1.50 11/30/2022792,600 shares $1.22 million -25.9%1.9%4.2 $1.54 11/15/20221,070,000 shares $1.89 million -4.5%2.6%5.3 $1.77 10/31/20221,120,000 shares $1.67 million -4.3%2.8%5.9 $1.49 10/15/20221,170,000 shares $1.60 million -14.6%2.9%5.7 $1.37 9/30/20221,370,000 shares $2.21 million +22.3%3.4%6.6 $1.61 9/15/20221,120,000 shares $2.02 million +24.4%2.8%4 $1.80 8/31/2022900,300 shares $2.11 million +1.9%2.2%3 $2.34 8/15/2022883,800 shares $2.55 million -23.8%2.2%2.6 $2.89 7/31/20221,160,000 shares $2.49 million +14.9%2.9%3 $2.15 7/15/20221,010,000 shares $2.30 million -8.2%2.5%2.5 $2.28The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him FIXX Short Interest - Frequently Asked Questions What is Homology Medicines' current short interest? Short interest is the volume of Homology Medicines shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 338,700 shares of FIXX short. 0.81% of Homology Medicines' shares are currently sold short. Learn More on Homology Medicines' current short interest. What is a good short interest ratio for Homology Medicines? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FIXX shares currently have a short interest ratio of 1.0. Learn More on Homology Medicines's short interest ratio. Which institutional investors are shorting Homology Medicines? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Homology Medicines: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Homology Medicines? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Homology Medicines' floating shares are currently sold short. Is Homology Medicines' short interest increasing or decreasing? Homology Medicines saw a increase in short interest in the month of February. As of February 29th, there was short interest totaling 338,700 shares, an increase of 5.1% from the previous total of 322,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Homology Medicines' float size? Homology Medicines currently has issued a total of 58,130,000 shares. Some of Homology Medicines' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Homology Medicines currently has a public float of 41,980,000 shares. How does Homology Medicines' short interest compare to its competitors? 0.81% of Homology Medicines' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Homology Medicines: Gain Therapeutics, Inc. (1.10%), Eledon Pharmaceuticals, Inc. (0.13%), Reneo Pharmaceuticals, Inc. (13.21%), Kronos Bio, Inc. (1.65%), Checkpoint Therapeutics, Inc. (12.35%), BioLineRx Ltd. (0.98%), SCYNEXIS, Inc. (2.75%), CalciMedica, Inc. (0.71%), Kezar Life Sciences, Inc. (5.25%), Equillium, Inc. (2.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Homology Medicines stock? Short selling FIXX is an investing strategy that aims to generate trading profit from Homology Medicines as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Homology Medicines? A short squeeze for Homology Medicines occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FIXX, which in turn drives the price of the stock up even further. How often is Homology Medicines' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FIXX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: GANX Short Squeeze ELDN Short Squeeze RPHM Short Squeeze KRON Short Squeeze CKPT Short Squeeze BLRX Short Squeeze SCYX Short Squeeze CALC Short Squeeze KZR Short Squeeze EQ Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FIXX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders